glp 1 asa Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 Agonists GLP-1 Receptor Agonists in Solid

Unique Weight Loss Solutions: What makes Rosaly Stephens, ARNP-Cs approach special

And millions of Americans who had been watching the weight loss drug market from the sidelines started asking the same question: Is this finally the easy, affordable way to get started on semaglutide or tirzepatide

In the 24-week study of patients receiving JANUVIA as add-on therapy to insulin (with or without metformin), there were no adverse reactions reported regardless of investigator assessment of causality in 5% of patients and more commonly than in patients given placebo, except for hypoglycemia (see Table 3)

At a high level, what appears to be most tangible about the experience of patients on GLP-1s is an abrupt reduction in cravings and compulsive behaviors and a sense of increased agency: the ability to make conscious decisions about what to consume, whether it is food or other substances, rather than feeling pulled by a strong internal urge

Researchers are actively studying these reactions to better understand why they happen and how to prevent them